Importance of hepatic artery node involvement in patients with colorectal liver metastases.

Por Dworkin, M J, Earlam, S, Fordy, C, Allen-Mersh, T G
Publicado em 1995

Hepatic arterial cannulation for regional chemotherapy is safe in patients with a liver metastasis volume of less than 1 litre.

Por Burke, D., Fordy, C., Earlam, S. A., Allen-Mersh, T. G.
Publicado em 1997

Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction.

Por Jonas, S, Windeatt, S, O-Boateng, A, Fordy, C, Allen-Mersh, T G
Publicado em 1996

Treatment interruptions and complications with two continuous hepatic artery floxuridine infusion systems in colorectal liver metastases.

Por Fordy, C., Burke, D., Earlam, S., Twort, P., Allen-Mersh, T. G.
Publicado em 1995

Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases.

Por Fordy, C., Glover, C., Davies, M. M., Allen-Mersh, T. G.
Publicado em 1998

Measurement of response to treatment in colorectal liver metastases.

Por Dworkin, M. J., Burke, D., Earlam, S., Fordy, C., Allen-Mersh, T. G.
Publicado em 1995

Relation between depression and circulating immune products in patients with advanced colorectal cancer.

Por Allen-Mersh, T G, Glover, C, Fordy, C, Henderson, D C, Davies, M
Publicado em 1998